文献速递免疫规划传染病防控与疫情报告

2011/2012至2014/2015四个流感季节流感疫苗接种保护作用的衰减

Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015.
PubMed 文献 · Vaccine · 2017-09-20

在四个流感季节连续纳入3615名接种疫苗后因流感住院的18岁及以上成人,采用检测阴性方法比较不同接种时间组住院风险。2011/2012和2014/2015两个A(H3N2)优势季节,晚期接种者住院风险低于早期接种者;65岁及以上人群中观察到疫苗效果衰减39%和31%。

要点

  • 2011/2012和2014/2015 A(H3N2)优势季节,晚期接种者住院风险低于早期接种者(aOR=0.68和0.69)。
  • 65岁及以上人群在两个A(H3N2)优势季节疫苗效果衰减分别为39%和31%。
  • 2012/2013 A(H1N1)pdm09优势季和2013/2014 B/Yamagata优势季未见晚期与早期接种者住院风险差异。

核心结论

  • 在两个A(H3N2)优势流感季节中,65岁及以上人群观察到流感疫苗保护作用的衰减。

研究设计与样本

  • 在四个流感季节连续招募18岁及以上、接种过季节性流感疫苗且随后经逆转录聚合酶链反应确诊因流感住院的个体。
  • 采用检测阴性方法,按疫苗接种日期三分位分为早期、中期和晚期接种,以早期接种为参照估算晚期接种者流感住院的调整比值比(aOR)。
  • 敏感性分析采用条件logistic回归、Cox比例风险回归以及以接种至住院天数替代接种日期进行分析。

主要发现

  • 3615名住院接种者中822人(23%)流感检测阳性。
  • 2011/2012和2014/2015 A(H3N2)优势季节,晚期接种者流感风险低于早期接种者:aOR=0.68(95%CI:0.47-1.00)和0.69(95%CI:0.50-0.95)。
  • 2012/2013 A(H1N1)pdm09优势季和2013/2014 B/Yamagata系优势季,晚期与早期接种者流感住院风险无差异:aOR=1.18(95%CI:0.58-2.41)和0.98(95%CI:0.56-1.72)。
  • 65岁及以上人群中,2011/2012和2014/2015 A(H3N2)优势季节晚期接种者住院风险低于早期接种者:aOR=0.61(95%CI:0.41-0.91)和0.69(95%CI:0.49-0.96)。
  • 65岁及以上人群在两个A(H3N2)优势季节疫苗效果衰减分别为39%(95%CI:9-59%)和31%(95%CI:5-50%)。

关键数值与推荐

  • 晚期接种者相对于早期接种者流感住院aOR:2011/2012季0.68(95%CI:0.47-1.00),2014/2015季0.69(95%CI:0.50-0.95)。
  • 65岁及以上人群相应aOR:2011/2012季0.61(95%CI:0.41-0.91),2014/2015季0.69(95%CI:0.49-0.96)。
  • 65岁及以上人群疫苗效果衰减:2011/2012季39%(95%CI:9-59%),2014/2015季31%(95%CI:5-50%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Concerns have been raised about intraseasonal waning of the protection conferred by influenza vaccination. METHODS: During four influenza seasons, we consecutively recruited individuals aged 18years or older who had received seasonal influenza vaccine and were subsequently admitted to the hospital for influenza infection, asassessed by reverse transcription polymerase chain reaction. We estimated the adjusted odds ratio (aOR) of influenza infection by date of vaccination, defined by tertiles, as early, intermediate or late vaccination. We used a test-negative approach with early vaccination as reference to estimate the aOR of hospital admission with influenza among late vaccinees. We conducted sensitivity analyses by means of conditional logistic regression, Cox proportional hazards regression, and using days between vaccination and hospital admission rather than vaccination date. RESULTS: Among 3615 admitted vaccinees, 822 (23%) were positive for influenza. We observed a lower risk of influenza among late vaccinees during the 2011/2012 and 2014/2015A(H3N2)-dominant seasons: aOR=0.68 (95% CI: 0.47-1.00) and 0.69 (95% CI: 0.50-0.95). We found no differences in the risk of admission with influenza among late versus early vaccinees in the 2012/2013A(H1N1)pdm09-dominant or 2013/2014B/Yamagata lineage-dominant seasons: aOR=1.18 (95% CI: 0.58-2.41) and 0.98 (95% CI: 0.56-1.72). When we restricted our analysis to individuals aged 65years or older, we found a statistically significant lower risk of admission with influenza among late vaccinees during the 2011/2012 and 2014/2015A(H3N2)-dominant seasons: aOR=0.61 (95% CI: 0.41-0.91) and 0.69 (95% CI: 0.49-0.96). We observed 39% (95% CI: 9-59%) and 31% (95% CI: 5-50%) waning of vaccine effectiveness among participants aged 65years or older during the two A(H3N2)-dominant seasons. Similar results were obtained in the sensitivity analyses. CONCLUSION: Waning of vaccine protection was observed among individuals aged 65years old or over in two A(H3N2)-dominant influenza seasons.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Puig-Barberà J, Mira-Iglesias A, Tortajada-Girbés M, et al. Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015. Vaccine. 2017. PMID: 28941618. doi:10.1016/j.vaccine.2017.09.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。